415,041 Shares in Danaher Corporation $DHR Acquired by Korea Investment CORP

Korea Investment CORP bought a new position in shares of Danaher Corporation (NYSE:DHR) in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 415,041 shares of the conglomerate’s stock, valued at approximately $79,057,000. Korea Investment CORP owned approximately 0.06% of Danaher at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Main Street Group LTD bought a new position in Danaher in the first quarter valued at $25,000. N.E.W. Advisory Services LLC bought a new position in shares of Danaher in the 2nd quarter valued at about $25,000. JPL Wealth Management LLC acquired a new stake in Danaher in the 3rd quarter valued at about $25,000. WFA of San Diego LLC bought a new stake in Danaher in the second quarter valued at approximately $26,000. Finally, Hilton Head Capital Partners LLC acquired a new position in shares of Danaher during the 4th quarter worth approximately $27,000. Institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently commented on DHR. Piper Sandler assumed coverage on shares of Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target on the stock. Guggenheim decreased their target price on shares of Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Royal Bank Of Canada raised their price objective on Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 22nd. TD Cowen dropped their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Finally, HSBC cut their target price on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Stock Performance

NYSE DHR opened at $219.42 on Friday. The firm’s 50 day simple moving average is $195.80 and its 200 day simple moving average is $192.61. The firm has a market capitalization of $154.25 billion, a price-to-earnings ratio of 38.97, a P/E/G ratio of 2.69 and a beta of 0.78. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same period in the prior year, the company earned $0.77 earnings per share. The company’s quarterly revenue was up 5.5% on a year-over-year basis. As a group, research analysts expect that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.